This post was originally published on this site People with high exposure to sunlight or ultraviolet radiation are significantly less likely to develop non-Hodgkin’s lymphoma compared to those with low exposure, but vitamin D levels in the body have no impact on disease incidence, a new study shows. The study, “Vitamin D status and risk…
Conditions
Conditions
Single Dose of Brachytherapy Safe, Effective for Localized PC, Study Shows
This post was originally published on this site Men with low-risk prostate cancer can safely receive a single high dose of brachytherapy — a type of radiation therapy delivered directly into the tumor within a few minutes — as an alternative treatment for their condition, a study shows. After three years of treatment, 100% of…
Family Caregivers of Dementia Patients May Benefit from Learning Positive Emotion Skills, Study Suggests
This post was originally published on this site An online program that teaches how to focus on positive emotions can help caregivers of family members with dementia to cope better with stress, and reduce their depression and anxiety symptoms, results from a clinical study suggest. The six-week skill-building intervention, called Life Enhancing Activities for Family…
Kadcyla Approved in US for Some HER2-positive Early Breast Cancer Patients
This post was originally published on this site The U.S. Food and Drug Administration (FDA) has extended the use of Genentech‘s Kadcyla (ado-trastuzumab emtansine) as an adjuvant (post-surgery) treatment for some patients with HER2-positive, early-stage breast cancer, the company announced. Specifically, the FDA’s approval is for patients who had residual disease after their pre-surgery treatment, which included a…
Famous Lymphoma Survivors Can Be Models for Hope
This post was originally published on this site I don’t like to think about death, much less write about it. Over 11 years as a follicular lymphoma patient, I’ve gotten pretty good at not thinking about it. But now and then, something happens that makes it unavoidable. Like when a famous person with lymphoma, such…
OncLive Poised to Induct 2019 Class of ‘Giants of Cancer Care’
This post was originally published on this site OncLive, a digital resource platform for oncologists, will welcome 15 new members at its 7th Annual Giants of Cancer Care Winners Reception on May 30 in Chicago, Illinois. Inductees are being recognized for furthering the field of oncology, including multiple myeloma, through research and clinical practices. “We are looking…
Dutch Researchers Develop Mini Ovarian Cancers to Improve Personalized Therapies
This post was originally published on this site Dutch researchers have developed a new experimental protocol that allowed them to culture mini ovarian cancers (organoids) in the lab that retained their three-dimensional structure and captured the cellular diversity seen in patients. These organoids, which mimic the cellular environment and treatment responses in patients, may be…
Despite Alzheimer’s, My Mom Never Lost Sight of Motherhood
This post was originally published on this site I recently discovered this article celebrating Mother’s Day and found it to be an enjoyable read because it rings true for me. Honest Abe earned his nickname All of us tend to be sentimental about our moms. Inspired by wonderful mothers, many of us could write 100…
UNC Launches Training Program to Improve Dementia Patients’ Care
This post was originally published on this site A new program called the Dementia Friendly Hospital Initiative is set to be launched in North Carolina to raise awareness among healthcare providers on how patients with Alzheimer’s disease and dementia experience care interventions and how to meet their needs. Led by the University of North Carolina…
Radiation Therapy Reduces Chances of Breast Cancer Returning in Women with Early, Hormone-Positive Disease, Trial Shows
This post was originally published on this site Women with early, low-risk hormone receptor-positive breast cancer are significantly less likely to see their disease return if given radiation therapy and hormone therapy following surgery, according to a trial that followed hundreds of women for nearly 10 years. Specifically, the trial found that whole breast irradiation…
Phase 3 Trial of Immune System-targeting Treatment for Advanced Multiple Myeloma Begins Dosing
This post was originally published on this site A pivotal Phase 3 clinical trial has begun dosing participants to evaluate MorphoSys‘s investigational antibody, MOR202 (TJ202), in combination with Revlimid (lenalidomide) plus dexamethasone, for the treatment of relapsed or refractory multiple myeloma. The study, ongoing in Taiwan, is being conducted by I-Mab Biopharma, which holds exclusive…
ctDNA Sampling May Help Tailor Treatment for Difficult-to-Treat Ovarian Cancer, Study Suggests
This post was originally published on this site An analysis of circulating tumor DNA, or ctDNA, can help guide treatment decisions for patients with difficult-to-treat high-grade serous ovarian cancer, a study shows. The study, “Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer,” was published in journal Precision Oncology. Cancers generally develop due…